87305
Tetrahexylammonium chloride
purum, ≥95.0% (AT)
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
[CH3(CH2)5]4N(Cl)
CAS Number:
Molecular Weight:
390.13
EC Number:
227-653-6
UNSPSC Code:
12352000
PubChem Substance ID:
Beilstein/REAXYS Number:
4605091
MDL number:
grade
purum
assay
≥95.0% (AT)
form
crystalline
reaction suitability
core: ammonium
ign. residue
≤0.5%
mp
111-113 °C (lit.)
SMILES string
[Cl-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC
InChI
1S/C24H52N.ClH/c1-5-9-13-17-21-25(22-18-14-10-6-2,23-19-15-11-7-3)24-20-16-12-8-4;/h5-24H2,1-4H3;1H/q+1;/p-1
InChI key
ODTSDWCGLRVBHJ-UHFFFAOYSA-M
Other Notes
Extraction of alkoxide anions into the organic phase
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
E.V. Dehmlow et al.
Tetrahedron, 41, 2927-2927 (1985)
N Surendran et al.
Journal of chromatography. B, Biomedical sciences and applications, 691(2), 305-312 (1997-04-11)
The objective of this research was to develop a rapid, sensitive and reliable method for the separation of phosphonodipeptide prodrugs and parent compounds to facilitate the evaluation of cell permeation using in vitro cell culture models. Separation was accomplished isocratically
Xuemei Wang et al.
Journal of biomedical materials research. Part A, 80(4), 852-860 (2006-10-31)
Although much effort has been extended to the efficient cancer therapies, the drug resistance is still a major obstacle in cancer chemotherapeutic treatments. Almost 90% of the cancer therapy failure is caused by the relative problems. Recently, the application of